Maximum tolerated dose of nalmefene in patients receiving epidural fentanyl and dilute bupivacaine for postoperative analgesia

Anesthesiology

Volumn 92, Issue 4, 2000, Pages 1010-1016

  Dougherty, Thomas B ^a   Porche, Vivian H ^b   Thall, Peter F ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

Dose finding trial designs; Dose response; Drug; Opioid antagonists

Indexed keywords

BUPIVACAINE; FENTANYL; NALMEFENE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; HUMAN; MALE; MAXIMUM PERMISSIBLE DOSE; PAIN ASSESSMENT; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0034111174     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200004000-00018     Document Type: Article

References (9)

1. Dixon R, Howes J, Gentile J, Hsu HB, Hsiao J, Garg D, Weilder D, Meyer M, Tuttle R: Nalmefene: Intravenous safety and kinetics of a new opioid antagonist. Clin Pharmacol Ther 1986; 39:49-53
2. Vizi ES, Foldes FF, Rich J, Knoll J: The structure-action relationship and kinetics of some naloxone and naltrexone derivatives. Pharmacology 1976; 14:76-85
3. Heilman RD, Gray MI, Chen RP, Hahn EF, Fishman J: An evaluation of the hot plate technique to study narcotic antagonists. Res Commun Chem Pathol Pharmacol 1976; 13:635-47
4. Thall PF, Lee JJ, Tseng CH, Estey EH: Accrual strategies for phase I trials with delayed patient outcome. Stat Med 1999; 18:1155-69
5. O'Quigley J, Pepe M, Fisher L: Continual reassessment method: A practical design for phase I clinical trials in cancer. Biometrics 1990; 46:33-48
6. Korn EL, Midthune D, Chen TT, Rubinstein LV, Christian MC, Simon RM: A comparison of two phase I trial designs. Stat Med 1994; 13:1799-806
7. Goodman SN, Zahurak ML, Piantadosi S: Some practical improvements in the continual reassessment method for phase I studies. Stat Med 1995; 14:1149-61
8. Cousins MJ, Mather LE: Intrathecal and epidural administration of opioids. ANESTHESIOLOGY 1984; 61:276-310
9. Rahimi A, Connelly NR, Parker RK: Prevention of intrathecal opioid-related side effects: Naloxone vs nalmefene (abstract). Anesth Analg 1997; 84:S404.